BRCA2 and cancer: It also suggests that population-matched and region-matched controls would be indispensable for precise risk estimation of cancer predisposition genes rather than ExAC and gnomAD.39 Taken together, more detailed information that accounts for populations and regions would improve precision medicine with genetic testing of BRCA1 and BRCA2.